Teachers Advisors LLC Reduces Position in Cerner (NASDAQ:CERN)

Teachers Advisors LLC cut its stake in Cerner (NASDAQ:CERN) by 2.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,331,765 shares of the company’s stock after selling 33,182 shares during the quarter. Teachers Advisors LLC owned approximately 0.40% of Cerner worth $89,748,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of the stock. BlackRock Inc. lifted its stake in Cerner by 2.2% in the 4th quarter. BlackRock Inc. now owns 19,519,304 shares of the company’s stock valued at $1,315,406,000 after buying an additional 420,942 shares in the last quarter. Capital International Investors lifted its stake in Cerner by 0.3% in the 3rd quarter. Capital International Investors now owns 4,851,296 shares of the company’s stock valued at $345,994,000 after buying an additional 12,178 shares in the last quarter. Geode Capital Management LLC lifted its stake in Cerner by 2.7% in the 4th quarter. Geode Capital Management LLC now owns 3,759,894 shares of the company’s stock valued at $252,916,000 after buying an additional 98,444 shares in the last quarter. American Century Companies Inc. lifted its stake in Cerner by 3.7% in the 4th quarter. American Century Companies Inc. now owns 3,204,461 shares of the company’s stock valued at $215,949,000 after buying an additional 114,224 shares in the last quarter. Finally, Legal & General Group Plc lifted its stake in Cerner by 1.8% in the 3rd quarter. Legal & General Group Plc now owns 1,477,451 shares of the company’s stock valued at $105,371,000 after buying an additional 25,842 shares in the last quarter. 78.54% of the stock is currently owned by hedge funds and other institutional investors.

In related news, Vice Chairman Clifford W. Illig sold 307,700 shares of Cerner stock in a transaction that occurred on Thursday, March 8th. The shares were sold at an average price of $64.52, for a total value of $19,852,804.00. Following the completion of the sale, the insider now owns 1,229,719 shares in the company, valued at approximately $79,341,469.88. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director William D. Zollars sold 4,100 shares of Cerner stock in a transaction that occurred on Thursday, February 8th. The shares were sold at an average price of $62.16, for a total transaction of $254,856.00. The disclosure for this sale can be found here. Insiders sold a total of 541,800 shares of company stock valued at $34,353,860 in the last quarter. 13.11% of the stock is owned by insiders.

Shares of NASDAQ CERN opened at $56.42 on Friday. The company has a market cap of $19,194.19, a PE ratio of 25.65, a PEG ratio of 1.68 and a beta of 0.96. The company has a debt-to-equity ratio of 0.11, a current ratio of 3.01 and a quick ratio of 2.99. Cerner has a 1 year low of $55.29 and a 1 year high of $73.86.

Cerner (NASDAQ:CERN) last announced its quarterly earnings results on Tuesday, February 6th. The company reported $0.58 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.61 by ($0.03). The firm had revenue of $1.31 billion for the quarter, compared to analyst estimates of $1.33 billion. Cerner had a return on equity of 16.82% and a net margin of 16.86%. The firm’s quarterly revenue was up 4.5% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.61 EPS. sell-side analysts expect that Cerner will post 2.42 EPS for the current fiscal year.

A number of research analysts recently weighed in on the stock. SunTrust Banks decreased their price target on shares of Cerner from $68.00 to $2.82 and set a “hold” rating on the stock in a research note on Wednesday, February 7th. Cantor Fitzgerald decreased their price target on shares of Cerner from $83.00 to $80.00 and set an “overweight” rating on the stock in a research note on Wednesday, February 7th. Argus downgraded shares of Cerner from a “buy” rating to a “hold” rating and increased their price objective for the company from $54.49 to $64.65 in a report on Tuesday, March 13th. BidaskClub downgraded shares of Cerner from a “sell” rating to a “strong sell” rating in a report on Thursday, March 15th. Finally, Evercore ISI assumed coverage on shares of Cerner in a report on Thursday, January 18th. They issued an “in-line” rating and a $77.00 price objective for the company. One investment analyst has rated the stock with a sell rating, twelve have issued a hold rating and ten have assigned a buy rating to the company’s stock. Cerner currently has an average rating of “Hold” and an average price target of $67.42.

WARNING: This article was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this article on another website, it was illegally copied and reposted in violation of U.S. and international trademark & copyright legislation. The correct version of this article can be viewed at https://www.dispatchtribunal.com/2018/04/07/teachers-advisors-llc-decreases-holdings-in-cerner-co-cern.html.

About Cerner

Cerner Corporation provides health care information technology solutions and services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.

Institutional Ownership by Quarter for Cerner (NASDAQ:CERN)

Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply